Tempus AI (NASDAQ:TEM) CEO Sells $12,319,125.00 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric Lefkofsky sold 166,250 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $74.10, for a total value of $12,319,125.00. Following the completion of the sale, the chief executive officer owned 9,008,033 shares in the company, valued at approximately $667,495,245.30. This represents a 1.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Tempus AI Stock Performance

NASDAQ TEM traded up $0.78 on Tuesday, reaching $76.84. 4,884,340 shares of the company’s stock traded hands, compared to its average volume of 11,165,074. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28. The firm has a market cap of $13.67 billion, a price-to-earnings ratio of -64.57 and a beta of 4.86. The stock has a 50 day moving average price of $83.45 and a 200-day moving average price of $72.29.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.05. The company had revenue of $334.21 million for the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The firm’s revenue for the quarter was up 84.7% compared to the same quarter last year. During the same period last year, the firm earned ($0.46) EPS. Tempus AI has set its FY 2025 guidance at EPS. Equities research analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Institutional Trading of Tempus AI

Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of Tempus AI by 6,247.5% in the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after acquiring an additional 5,900,668 shares during the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd raised its position in Tempus AI by 109.9% in the first quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 50,666 shares of the company’s stock valued at $2,444,000 after purchasing an additional 26,533 shares during the period. Jump Financial LLC purchased a new stake in Tempus AI in the first quarter valued at approximately $8,545,000. Tyler Stone Wealth Management acquired a new position in Tempus AI during the first quarter worth $386,000. Finally, Salem Investment Counselors Inc. boosted its position in shares of Tempus AI by 8,020.0% during the second quarter. Salem Investment Counselors Inc. now owns 30,450 shares of the company’s stock worth $1,935,000 after buying an additional 30,075 shares during the period. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on TEM. Morgan Stanley boosted their price objective on Tempus AI from $68.00 to $80.00 and gave the company an “overweight” rating in a research report on Tuesday, November 11th. Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating in a research note on Tuesday, October 21st. BTIG Research upped their price objective on shares of Tempus AI from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday. Canaccord Genuity Group decreased their price objective on shares of Tempus AI from $110.00 to $95.00 and set a “buy” rating on the stock in a report on Wednesday, November 5th. Finally, TD Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price for the company. in a research note on Tuesday, October 21st. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $80.75.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.